Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Mainz Biomed NV (MYNZ) had Cash Flow from Financial Activities of $2.68M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$3.09M |
|
$1.39M |
|
$6.72M |
|
$9.80M |
|
$5.99M |
|
$1.10M |
|
$1.29M |
|
$7.28M |
|
$2.52M |
|
$-1.49M |
|
$2.52M |
|
4.09M |
|
| Cash Flow Statement Financials | |
$-6.52M |
|
$-0.45M |
|
|
Cash Flow from Financial Activities |
$2.68M |
$6.24M |
|
$1.91M |
|
$-4.32M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|